Results 131 to 140 of about 24,005 (199)

Multi-omics analysis reveals PIAS family gene dysregulation as a driver of head and neck squamous cell carcinoma (HNSC) progression and therapeutic vulnerability. [PDF]

Discov Oncol
Hussain M, Ishfaq M, Hameed SA, Abbas AS, Bhanbhro MUR, Ain QU, Abdel-Maksoud MA, Alamri A, Almutairi S, Almanaa TN, Ayaz MM, Hameed Y.   +11 more
europepmc   +1 more source

Targeting hypoxia-inducible factor-1 in a hypoxidative stress model protects retinal pigment epithelium cells from cell death and metabolic dysregulation. [PDF]

Cell Death Discov
Schubert A, Lobo Barbosa da Silva ME, Ambrock T, Terosian O, Malyshkina A, Padberg C, Larafa S, Matschke J, Fandrey J, Henning Y.   +9 more
europepmc   +1 more source

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas. [PDF]

ESMO Open
Filippini DM, Cabarrou B, Dupain C, Halladjian M, Coquan E, Sablin MP, Mazzarella L, Francisco M, Servant N, Tonini MM, Hundt AF, Castel-Ajgal Z, You B, Bigot F, Ghiringhelli F, Vansteene D, Gomez-Roca C, Cousin S, Lambert A, Saada-Bouzid E, Durando X, Abdeddaim C, Borel C, Chaltiel R, Borcoman E, Legrand F, Bernhart S, Jimenez M, Bièche I, Filleron T, Le Tourneau C, Kamal M, Jeannot E.   +32 more
europepmc   +1 more source

Methotrexate/tacrolimus/vorinostat

Reactions Weekly, 2022
openaire   +1 more source

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy. [PDF]

Cells
Hawash M.
europepmc   +1 more source

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma. [PDF]

Int J Mol Sci
Brumfield GL, Doty KR, Knoche SM, Larson AC, Gephart BD, Coulter DW, Solheim JC.   +6 more
europepmc   +1 more source

The Systematic Comparison of Enhancer of Zeste Homolog-2-, Bromodomain-containing Proteins-, Histone Deacetylase-, and DNA-methyltransferase 1-inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti-tumoral and Immunomodulatory Activities. [PDF]

MedComm (2020)
Rigo V, Amaro A, Reggiani F, Fenoglio D, Martini S, Altosole T, Petito M, Profumo C, Croce M.   +8 more
europepmc   +1 more source

The Combination Therapy With Sorafenib in Therapeutic Strategy of Acute Myeloid Leukemia. Is It Promising? A Narrative Review. [PDF]

Health Sci Rep
Shamahmood MN, Miri A, Mezginejad F.
europepmc   +1 more source

Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemia. [PDF]

Discov Oncol
Balaji S, Anbarasu S, Ramaiah S, Anbarasu A.   +3 more
europepmc   +1 more source

An in Vitro Study on Anticancer Efficacy of Capecitabine- and Vorinostat-incorporated Self-nanoemulsions. [PDF]

J Biomed Phys Eng
Nazari-Vanani R, Sattarahmady N, Karimian K, Heli H.   +3 more
europepmc   +1 more source